Ceva continues rapid growth in 2011 >

Twin pillar strategy of combining internal and external growth opportunities drives further global expansion

Transmune.com goes online ! >

CEVAC TRANSMUNE, the innovative vaccine for the control of Gumboro Disease, used in more than 50 countries is now online on Transmune.com !!

Second joint Human and Veterinary Cardiology Symposium >

Together for health, in the heart of Bordeaux

Ceva acquires Vetech Laboratories, Inc. >

Move adds significant poultry vaccine to innovative portfolio

Ceva Swine Team conduct latest symposium >

Actinobacillus pleuropneumoniae: the latest scientific research applied to field control strategies.

Instituto Sanidad Ganadera, Argentina acquired by Ceva >

New company will build on strong biological expertise and expand Ceva’s platform in South American zone.

Joint Venture agreement between Ceva and Huadu signed in Beijing >

“Ceva Huadu” to become Innovation & R&D platform for biologicals

Vector vaccines symposium - 23th September 2010 >

CEVA will hold its first vector vaccines symposium in San Diego, USA from october 6-8th2010. Together with presenting its advanced technology, the forum will encourage the sharing of worldwide experie...

Contact >

Group overview >

Driven to innovate and with a proven record of double-digit growth, Ceva is one of the fastest growing top 10 animal healthcare companies. Our vision reaches far beyond animal health and welfare.